Weekly News Recap #Phispers
FDA agrees to review Moderna’s amended mRNA-based flu vaccine application; Lilly builds orforglipron stock ahead of approval

FDA agrees to review Moderna’s amended mRNA-based flu vaccine application; Lilly builds orforglipron stock ahead of approval

Last week, the US Food and Drug Administration (FDA) had said it will not review Moderna’s application for its experiment...

Impressions : 1870